In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against <i>Mycobacterium tuberculosis</i>.

In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against <i>Mycobacterium tuberculosis</i>.

<b>Background</b> : The increasing incidence of drug-resistant Mycobacterium tuberculosis necessitates therapeutic alternatives. The fluoroquinolones fulfill most of the criteria for an ideal class of antimycobacterial drugs. The aim of the present study was to determine to in vitro acti...

Full description

Bibliographic Details
Main Authors:	Akcali Sinem, Surucuoglu Suheyla, Cicek Candan, Ozbakkaloglu Beril
Format:	Article
Language:	English
Published:	King Faisal Specialist Hospital and Research Centre 2005-01-01
Series:	Annals of Saudi Medicine
Online Access:	http://www.saudiannals.net/article.asp?issn=0256-4947;year=2005;volume=25;issue=5;spage=409;epage=412;aulast=Akcali

Similar Items

A study of ofloxacin and levofloxacin photostability in aqueous solutions
by: Anita Frąckowiak, et al.
Published: (2016-12-01)

Prevalence of GBV-C/hepatitis G virus viremia among chronic hepatitis B, chronic hepatitis C and hemodialysis patients in Turkey
by: Akcali Sinem, et al.
Published: (2006-01-01)

Susceptibility of Rifampicin-Isoniazid Resistant Mycobacterium Tuberculosis Isolates Against Levofloxacin
by: A. H. Kurniawan, et al.
Published: (2016-01-01)

Genetic polymorphism and phenotypic resistance of Mycobacterium tuberculosis to ofloxacin and moxifloxacin
by: D. V. Vаkhrushevа, et al.
Published: (2020-12-01)

Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration
by: Tatsuya Sakai, et al.
Published: (2019-08-01)

Noncytotoxic Pyrrolobenzodiazepine–Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis
by: Pietro Picconi, et al.
Published: (2019-12-01)

Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against <i>Elizabethkingia anophelis </i>using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal Models
by: Jiun-Nong Lin, et al.
Published: (2021-03-01)

Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis
by: Min Qiao, et al.
Published: (2021-05-01)

Evaluate the Protective Effect of Lactobacillus against Collateral Damage Induced by Ciprofloxacin and Levofloxacin in Iraqi Patients
by: Ali F. Hassan, et al.
Published: (2019-12-01)

Transmission Electron Microscopy of XDR Mycobacterium tuberculosis Isolates Grown on High Dose of Oﬂoxacin
by: Mohammad Arjomandzadegan, et al.
Published: (2017-02-01)

Susceptibility of conjunctival bacterial pathogens to fluoroquinolones. A comparative study of ciprofloxacin, norfloxacin and ofloxacin
by: Stella Odjimogho, et al.
Published: (2003-10-01)

Relationship between the Susceptibility of Salmonella.Typhi to Ciprofloxacin, Ofloxacin and their respective Susceptibility To Nalidixic Acid
by: Nabila Bashir, et al.
Published: (2018-07-01)

Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis
by: Dehong Cao, et al.
Published: (2021-04-01)

Molecular detection of drug resistance to ofloxacin and kanamycin in Mycobacterium tuberculosis by using multiplex allele-specific PCR
by: Richa Kumari, et al.
Published: (2018-01-01)

Inhibition Effect of Antibiotics Ciprofloxacin and Ofloxacin and Hormone-Stradiol 17Valerat on the Methanogenic Activity of Anaerobic Biomass
by: M Heidari, et al.
Published: (2011-06-01)

Novel Isoniazid-Carborane Hybrids Active in Vitro Against <i>Mycobacterium tuberculosis</i>
by: Daria Różycka, et al.
Published: (2020-12-01)

Conjugates of Ciprofloxacin and Levofloxacin with Cell-Penetrating Peptide Exhibit Antifungal Activity and Mammalian Cytotoxicity
by: Natalia Ptaszyńska, et al.
Published: (2020-06-01)

Molecular typing and profiling of topoisomerase mutations causing resistance to ciprofloxacin and levofloxacin in Elizabethkingia species
by: Ming-Jr Jian, et al.
Published: (2018-09-01)

Molecular Diversity of Drug Resistant Mycobacterium Tuberculosis Strains in Western Turkey
by: Hörü Gazi, et al.
Published: (2012-06-01)

Genotype analysis of ofloxacin-resistant multidrug-resistant Mycobacterium tuberculosis isolates in a multicentered study from India
by: Anamika Gupta, et al.
Published: (2020-01-01)

Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
by: Sirous M, et al.
Published: (2018-10-01)

Prevalence of Multidrug Efflux Pump Requiring Ciprofloxacin, Ofloxacin and Pefloxacin as Substrates, Among Clinical Isolates of Pseudomonas aeruginosa
by: Omoregie, R., et al.
Published: (2007-01-01)

Cutaneous Mycobacterium fortuitum infection: Successfully treated with amikacin and ofloxacin combination
by: Sunil Sethi, et al.
Published: (2014-01-01)

Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway
by: Morena Zusso, et al.
Published: (2019-07-01)

Probable Levofloxacin-Induced Thrombocytopenia in a Patient Previously on Ciprofloxacin: A Case Report and Literature Review
by: A. Justine Landi, et al.
Published: (2016-01-01)

In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa
by: Vladimir Chachanidze, et al.
Published: (2009-01-01)

High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.
by: N Selvakumar, et al.
Published: (2015-01-01)

Penetration of 0.3% ciprofloxacin, 0.3% ofloxacin, and 0.5% moxifloxacin into the cornea and aqueous humor of enucleated human eyes
by: G.C.M. Silva, et al.

Levofloxacin-Proliposomes: Opportunities for Use in Lung Tuberculosis
by: Teerapol Srichana, et al.
Published: (2012-08-01)

Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene
by: Fengmin Huo, et al.
Published: (2020-03-01)

The Roles of Inflammasomes in Host Defense against <i>Mycobacterium tuberculosis</i>
by: Jialu Ma, et al.
Published: (2021-01-01)

A new in vitro dormancy model of <i>Mycobacterium tuberculosis</i>
by: Ya. R. Bаtyrshinа, et al.
Published: (2020-04-01)

Multiple mechanisms contributing fluoroquinolone (ciprofloxacin, levofloxacin,moxifloxacin) resistance in neonatal septicaemic A. baumannii from India
by: S. Roy, et al.
Published: (2020-12-01)

Specific patterns of <it>gyr</it>A mutations determine the resistance difference to ciprofloxacin and levofloxacin in <it>Klebsiella pneumoniae</it> and <it>Escherichia coli</it>
by: Fu Yingmei, et al.
Published: (2013-01-01)

Association of mutation patterns in <it>gyrA/B </it>genes and ofloxacin resistance levels in <it>Mycobacterium tuberculosis </it>isolates from East China in 2009
by: Huang Xiaochen, et al.
Published: (2011-03-01)

Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus
by: Mohammad Arjomandzadegan, et al.
Published: (2016-01-01)

Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies.
by: Antoine Grillon, et al.
Published: (2016-01-01)

Frequency and implications of ofloxacin resistance among previously treated tuberculosis patients
by: Jyoti Arora, et al.
Published: (2019-04-01)

Antimicrobial Peptide against <i>Mycobacterium Tuberculosis</i> That Activates Autophagy Is an Effective Treatment for Tuberculosis
by: Erika A. Peláez Coyotl, et al.
Published: (2020-11-01)

Ofloxacin Induced Hypomania
by: Siddharth Sarkar, et al.
Published: (2013-07-01)

Cannot write session to /tmp/vufind_sessions/sess_a0icl2v4f2usug2pp1gjd8m6rv